Article Information
History
- March 17, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Elna Dickson1,#,
- Amoolya Sai Dwijesha2,#,
- Natalie Andersson3,
- Sofia Lundh2,4,
- Maria Björkqvist1,
- Åsa Petersén2 and
- Rana Soylu-Kucharz1,*
- 1Biomarkers in Brain Disease, Department of Experimental Medical Science, Lund University, Sweden
- 2Translational Neuroendocrine Research Unit, Department of Experimental Medical Science, Lund University, Sweden
- 3Pathways of cancer cell evolution, Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden
- 4Department of Pathology and Imaging, Global Drug Discovery, Novo Nordisk A/S, Denmark
- ↵*Address for correspondence: Rana Soylu-Kucharz, Translational Neuroendocrine Research Unit, BMC D11, 221 84 Lund, Sweden, E-mail: rana.soylu_kucharz{at}med.lu.se